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Background: Ruta graveolens L. (R. graveolens) is a medicinal plant employed in non-traditional medicines that
has various therapeutic properties, including anthelmintic, and vasodilatory actions, among others. We evaluated
the trachea-relaxant effects of hydroalcoholic extract of R. graveolens against potassium chloride (KCl)- and
carbachol-induced contraction of rat tracheal rings in an isolated organ bath.
Results: The results showed that the airway smooth muscle contraction induced by the depolarizing agent (KCl)
and cholinergic agonist (carbachol) was markedly reduced by R. graveolens in a concentration-dependent manner,
with maximum values of 109 ± 7.9 % and 118 ± 2.6 %, respectively (changes in tension expressed as positive
percentages of change in proportion to maximum contraction), at the concentration of 45 μg/mL (half-maximal
inhibitory concentration IC50: 35.5 μg/mL and 27.8 μg/mL for KCl- and carbachol-induced contraction, respectively).
Additionally, the presence of R. graveolens produced rightward parallel displacement of carbachol dose–response
curves and reduced over 35 % of the maximum smooth muscle contraction.
Conclusions: The hydroalcoholic extract of R. graveolens exhibited relaxant activity on rat tracheal rings. The results
suggest that the trachea-relaxant effect is mediated by a non-competitive antagonistic mechanism. More detailed
studies are needed to identify the target of the inhibition, and to determine more precisely the pharmacological
mechanisms involved in the observed biological effects.
Keywords: Ruta graveolens, Trachea-relaxant, Plant extractBackground
Asthma is an airway allergic inflammatory disease charac-
terized by bronchospasms, intermittent chronic inflamma-
tion, and airway remodeling [1, 2]. Meanwhile, chronic
obstructive pulmonary disease (COPD) is a progressive
pathology characterized by increased airflow restriction [3,
4]. In recent years, efforts to develop more beneficial and
safer therapies for these conditions have increased, focus-
ing on prevention rather than treatment of the active
diseases [5, 6]. The current challenge in research is to
identify the molecular mediators and mechanisms
involved in the pathophysiology of such diseases [7, 8].* Correspondence: luis.aguila.paredes@gmail.com
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creativecommons.org/publicdomain/zero/1.0/Thus, several pharmacological studies of natural products
capable of relaxing the airway smooth muscle to improve
the airflow have been ongoing, and are considered as
alternative treatments.
Several plants of the Rutaceae family are used in non-
traditional medicines around the world. The most com-
mon plant is Ruta graveolens L (R. graveolens), popularly
known as “Ruta”. This plant was brought to Chile from
southern Europe. In folk medicines, it has mainly been
used for menstrual problems, respiratory diseases, and
gastrointestinal disorders [9, 10]. In several scientific
reports, R. graveolens has been described to have
hypotensive [11], spasmolytic [12], anti-inflammatory [13],
sperm motility-inhibitory [14], algaecidal and antifungal
[15], and antimicrobial [16] properties, and even to act as
an anti-carcinogenic agent [17] and antioxidant [18–20].
Nevertheless, despite the many studies carried out on
the biological effects of R. graveolens, there are no scien-
tific data about its effects on airway contractility. Thus, asticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Fig. 1 Dose–response curve of tracheal smooth muscle contraction
induced by carbachol (0.1, 1.0, 10, and 100 μM). Symbols and vertical
bars represent means and SEM (n = 3 biological replicates)
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de La Frontera to characterize the bioactive actions of
R. graveolens, the aim of this study was to perform phyto-
chemical screening of a hydroalcoholic extract of this
plant and to evaluate its trachea-relaxant potential on
agonist-induced rat tracheal ring contraction.
Results
Chromatogram analysis and identification of signals
Our phytochemical screening of the hydroalcoholic ex-
tract revealed the presence of secondary metabolites with
potential biological effects (quercetin, rutin, and psoralen)
(Table 1). Thus, this ethanolic extract was selected for
further study.
Airway smooth muscle contraction by carbachol:
determination of EC50
Increasing concentrations of carbachol (0.1–100 μM)
caused concentration-dependent contraction in tracheal
preparations with an EC50 value of 0.2 μM, reflecting the
maximum contraction obtained with 100 μM carbachol
(Fig. 1).
R. graveolens extract induces relaxation of contracted rat
tracheal rings to a similar level to aminophylline
In the tracheal ring preparations, increasing concentra-
tions of the R. graveolens extract (5, 15, 30, and 45 μg/mL)
significantly reduced (p < 0.001) the muscle tension in-
duced by carbachol in a concentration-dependent manner,
with the maximum value of 118 ± 2.6 % (n = 5) obtained
at a concentration of 45 μg/mL (EC50: 27.8 μg/mL)
(Fig. 2). Meanwhile, in potassium chloride (KCl)
pre-contracted tracheal rings, the muscle tension was
reduced by the R. graveolens extract (5–45 μg/mL) in a
concentration-dependent manner, with the maximum
value of 109 ± 7.9 % obtained at a concentration of 45
μg/mL (EC50: 35.5 μg/mL) (Fig. 3). The plant extract
achieved relaxant effects at a similar level to those of ami-
nophylline. However, the relaxant effects of R. graveolens
at 5 and 15 μg/mL were significantly lower than those of
0.2 and 0.4 mM aminophylline (Figs. 2 and 3). Aminophyl-
line (0.2, 0.4, 0.8, and 1.0 mM) significantly decreased
(p < 0.001) the muscle tension induced by carbachol
and KCl in a concentration-dependent manner, withTable 1 Signal identification
Retention
time (min)
Q1 Precursor ions Q3 Fragment Ions Compounds
19.55 187 131/115 Psoralen
19.64 303 229/153 Quercetin
17.70 611 303/465 Rutin
Identification of the compounds in each sample of the R. graveolens extract,
analyzed by comparisons with standards in both retention times and fragment
settings/specific precursorsmaximum values of 104 ± 6.4 % and 106 ± 5.7 %,
respectively (EC50: 6.3 μM and 6.0 μM for carbachol
and KCl, respectively) (Figs. 2 and 3).
Antagonist-like effect of the R. graveolens extract against
carbachol-induced tension
To confirm the antagonist-like effect, dose–response
curves of carbachol were constructed in the presence of
the plant extract or vehicle medium. Pretreatment with
the R. graveolens extract at 15, 30, and 45 μg/mL for
20 min produced rightward parallel displacement of the
carbachol curves and reduced the maximum contractionFig. 2 Effects of different concentrations of the R. graveolens extract
(5–45 μg/mL) on carbachol (1 μM) pre-contracted rat tracheal rings.
Concentrations of R. graveolens: C1, 5 μg/mL; C2, 15 μg/mL; C3,
30 μg/mL; C4, 45 μg/mL. Concentrations of aminophylline: C1,
0.2 mM; C2, 0.4 mM; C3, 0.8 mM; C4, 1.0 mM. Symbols and vertical
bars represent means and SEM (n = 5 biological replicates). Data with
different superscript symbols differ significantly among groups:
*p < 0.05; **p < 0.01
Fig. 3 Effects of different concentrations of the R. graveolens extract
(5–45 μg/mL) on KCl (80 mM) pre-contracted rat tracheal rings.
Concentrations of R. graveolens: C1, 5 μg/mL; C2, 15 μg/mL; C3,
30 μg/mL; C4, 45 μg/mL. Concentrations of aminophylline: C1,
0.2 mM; C2, 0.4 mM; C3, 0.8 mM; C4, 1.0 mM. Symbols and vertical
bars represent means and SEM (n = 5 biological replicates). Data with
different superscript symbols differ significantly among groups:
*p < 0.05; **p < 0.01
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ively (Fig. 4).
Discussion
Stimulation of airway calcium-activated potassium chan-
nels induces a sustained increase in the intracytoplasmic
calcium concentration in smooth muscle cells [21] and
is considered to play a significant role in the pathogenic
changes associated with asthma [22]. Meanwhile, carba-
chol induces contraction of the smooth muscle cells by
releasing sarcoplasmic calcium, followed by rapid entryFig. 4 Dose–response curves for carbachol constructed in the
presence of the R. graveolens extract (15, 30, and 45 μg/mL).
Symbols and vertical bars represent means and SEM (n = 4 biological
replicates). Data with different superscript symbols differ significantly
among groups: p < 0.05of calcium to the cells [23, 24], thereby stimulating
1,4,5-inositol trisphosphate receptors (IP3Rs) and ryano-
dine receptors (RyRs) [25], both of which are involved in
asthma pathophysiology [26]. In the present study, the
R. graveolens plant extract was capable of significantly
reducing the smooth muscle tension of rat tracheal
rings subjected to contraction by a cholinergic agonist
(carbachol) and a depolarizing agent (KCl) (Figs. 2 and
3, respectively). Additionally, our previous report dem-
onstrated the presence of cytotoxic effects with high
concentrations only of the R. graveolens extract (above
400 μg/mL) using an endothelial cellular model [27].
Similarly, previous studies have demonstrated myore-
laxant effects of plants from the Rutaceae family
[28, 29]. For example, it has been indicated that a
hydroalcoholic extract of Ruta chalepensis decreased
KCl-induced contraction of the rat ileum, probably by
increasing the production of nitric oxide (NO) and
cyclic guanosine monophosphate (GMPc) [30]. Other
authors have described that benzofurans, acridinons,
psoralens, and other coumarins present in plants from
the Rutaceae family are able to block potassium cur-
rents [31, 32].
Pharmacologically, a competitive antagonist blocks the
chain of reactions produced by an agonist, as the antag-
onist acts on a different site in the receptor within the
effector system [33]. Thus, dose–response curves for
carbachol (0.1–100 μM) were constructed in the pres-
ence of the R. graveolens extract (5, 10, and 35 μg/mL)
(Fig. 4). The obtained data suggested that our plant
extract acted as a non-competitive antagonist, because
as the dose of R. graveolens increased, the maximum ef-
fect exerted by the cholinergic agonist gradually de-
creased and produced rightward parallel displacement of
the carbachol curves.
Among the chemical components present in the R.
graveolens extract and likely to be responsible for its
proven bioactivity are alkaloids, rutin [34], furanocou-
marins (psoralen, xanthotoxin, bergapten) [35], acri-
done epoxides, acridone glucosides, gravacridondiol,
and the greatest alkaloid in R. graveolens root, rutacri-
done [36–39]. Within the active principles described in
plants, rutin, a natural flavonoid present in many herb
families (Polygonaceae, Rutaceae, and Violaceae), has
shown dose-dependent relaxant effects in the rat duode-
num [40] and can decrease lipopolysaccharide-induced
NO synthesis in vivo [41]. It has been established that a
methanolic extract of R. graveolens contains approxi-
mately 4 % rutin [42]. Another study considered that
coumarin compounds of an aqueous extract of R. grave-
olens were probably capable of blocking ionic currents
[43]. Our phytochemical screening by liquid chroma-
tography of a hydroalcoholic extract of R. graveolens re-
vealed the presence of flavonoids (quercetin and rutin)
Águila et al. Biological Research  (2015) 48:28 Page 4 of 6and a furanocoumarin (psoralen), which are probably
responsible for the bioactive effects revealed here.
Conclusions
In conclusion, the main contributions of the present
study are the first description of the relaxant effects of
R. graveolens on rat tracheal smooth muscle and the cor-
relation with its popular use in respiratory diseases. The
trachea-relaxant effect can be explained through a non-
competitive antagonistic mechanism, possibly involving
the blockade of ionic currents. However, more detailed
studies are needed to identify the target of the inhibition,
and to determine more precisely the pharmacological
mechanisms involved in the observed biological effects.
Methods
Animals
All the animals used in the procedures in this study were
treated in accordance with international principles and
local regulations concerning the care and ethical use of
laboratory animals. The experimental protocol was ap-
proved by the Bioethical Commission of the University
of La Frontera, presented to the Bioethical National
Committee in CONICYT, and revised by the FONDEF
Committee. Sprague–Dawley rats weighing 200–250 g
were used in the experiments and purchased from the
Animal Breeding Laboratory of the University of La
Frontera. The animals were maintained under controlled
environmental conditions, with room temperature at
18–22 °C, an alternating 12-h/12-h light/dark cycle, and
ad libitum water, and feeding with a standardized pellet.
Drugs and chemicals
Carbachol, anhydrous aminophylline, and KCl were
acquired from Sigma-Aldrich (USA). The final concen-
tration of KCl (80 mM) was selected on the basis of pre-
vious studies [44, 45].
Extract preparation
Leaves and aerial parts of R. graveolens were collected at
Temuco in Southern Chile (38° 44′ 52″ S; 72° 37′ 3″
W; 200 m above sea level). The material was identified
by Professor Fernando Romero, Faculty of Medicine,
University of La Frontera.
For the purpose of organic extraction, the plant extract
was prepared by washing R. graveolens leaves with de-
ionized water (Simplicity 185; Millipore, Germany), and
drying at 37 °C. The dried leaves were then pulverized,
extracted with ethanol/water (4:1) for 3 days, filtered in
a vacuum, concentrated in a rotary evaporator, and
subjected to lyophilization at −80 °C for 2 days (Chris
Alpha1-2; Osterade, Germany) to obtain a viscous mass
of dark green extract. Just prior to biological testing, the
extract was dissolved in vehicle solution (ethanol 0.1 %,cremophor 0.1 %, dimethylsulfoxide 0.1 %, n-hexanol
0.1 %) to prepare a stock solution of 10 mg/mL.Phytochemical screening
The hydroalcoholic freeze-dried R. graveolens extract
was subjected to phytochemical screening to detect the
presence of alkaloids. Briefly, 100 mg of the sample (R.
graveolens extract) was dissolved in 4 mL of methanol,
from which a 150-μL aliquot was taken for examination
on a LC-MS MS system, consisting of a liquid chro-
matograph (Shimadzu, Japan) connected to MDS Sciex
Mass Spectrometer QTRAP 3200 (Applied Biosystems,
USA), equipped with an electrospray ionization (ESI)
source Turbo V™ (AB Sciex, Singapore) at 450 °C. Chro-
matographic separation was performed with a RP-C18
Column Inertsil ODS-3 (2.1 × 150 mm, 3 mm) (GL Sci-
ences, USA) using an injection volume of 10 μL, a flow
rate of 0.2 mL/min, and a column temperature of 35 °C.
To separate the standards and samples, a gradient con-
sisting of solvent A (water/acetic acid, 99.9:0.1, v/v), and
solvent B (methanol) was applied, followed by a 5-min
equilibration between each sample. Data acquisition was
performed using the software Analyst 1.5.1 (Applied
Biosystems, USA). The ESI parameters were as follows:
Cur gas: 137.9 kPa; CAD gas: medium; Gas1: 60 psi;
Gas2: 30 psi; capillary voltage: 3500 V. For analysis of
samples, the Multiple Reaction Monitoring method was
used with three compounds in positive polarity and two
transitions for each. The retention times of the standards
and their transition precursor ions/fragment ions were
considered as the positive identification parameters.Preparation of isolated trachea and tension measurement
The animals were euthanized by cervical dislocation and
their tracheas were removed. The isolated tracheas were
dissected, and connective and adipose tissue adhesions
were removed. A tracheal segment was cut into trans-
verse rings of 3–5 mm, followed by connection of the
lower and upper extremes to a isometric force trans-
ducer LabChart pro 6.1 (ADInstruments, CO, USA) in
an isolated organ bath with modified Tyrode’s solution
(in mM: NaCl 137; KCl 5.4; CaCl2.2H2O 2.7;
MgCl2.6H2O 0.5; NaHCO3 11.9; NaH2PO4.H2O 0.45)
containing 5.55 mM glucose monohydrate. The solu-
tion was maintained at 37 °C and pH 7.3, with constant
bubbling of 5 % CO2 and 95 % O2. The tension was
continuously measured by the force transducer. To
reach spontaneous equilibration, a tension of 1 g was
applied initially for 30 min [46]. To verify the integrity
of the tracheal tissue, 80 mM KCl was added initially
during each experiment, and only responsive tracheal
rings were included in the study.
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To determine the EC50 of carbachol, dose–response
curves were recorded using increasing concentrations
of the reagent (0.1–100 μM) starting with the basal ten-
sion of the rings at approximately 1 g. Changes in the
force transducer were analyzed as the percentage of
change in tension from the baseline (1 g) to the peak of
each dose, with approximately 15-min intervals be-
tween each treatment.
Determination of R. graveolens effects on
contractile activity
The trachea-relaxant effects of increasing concentrations
(C1, 5 μg/mL; C2, 15 μg/mL; C3, 30 μg/mL; C4, 45 μg/mL)
of the hydroalcoholic extract of R. graveolens versus those
of anhydrous aminophylline (C1, 0.2 mM; C2, 0.4 mM; C3,
0.8 mM; C4, 1.0 mM), as one of the main drugs used to
prevent and treat asthma, chronic bronchitis, and other
lung diseases [47], were examined. Vehicle (25 μL) was
used as a negative control. An increase in tone (contrac-
tion) was induced with carbachol (1 μM; 80 % maximum
response obtained) or KCl (80 mM). In each experiment,
the effects of the four increasing concentrations of the ex-
tract, aminophylline, or vehicle on the contracted tracheal
smooth muscle were measured after exposing the tracheal
segment to each concentration of the solution for 15 min.
A decrease in tone was considered to be a relaxant effect,
and expressed as a positive percentage change in propor-
tion to the maximum contraction.
With the purpose of establishing the possible antagonis-
tic effect of the plant extract, the rings were pre-incubated
with 15, 30, and 45 μg/mL of R. graveolens extract for at
least 20 min [48] and then induced to contract by adding
increasing concentrations of carbachol (0.1, 1.0, 10, and
100 μM).
Statistical analysis
The data for the different functional parameters evaluated
were expressed as means ± SEM. Differences between the
groups were analyzed by one-way analysis of variance
(ANOVA) followed by Tukey multiple comparison tests.
Values of p < 0.05 were considered to be significant. For
the tension analysis, LabChart5.0 was used, with data
processing by Origin 6 for the dose–response curves.
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